{"id":"https://genegraph.clinicalgenome.org/r/8603deb0-70e2-48f4-b485-07ddc487d8a0v1.0","type":"EvidenceStrengthAssertion","dc:description":"LPIN2 was first reported in relation to autosomal recessive Majeed syndrome in 2005 (Ferguson PJ et al., PMID: 15994876). The syndrome of pediatric-onset congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis was first described in 1989, along with its association with Sweetâ€™s syndrome (Majeed HA et al., PMID: 2809904). Over the years, case reports have expanded the phenotype to include recurrent fevers, elevated acute phase reactants and hepatosplenomegaly. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism, inheritance pattern, nor phenotypic variability. Therefore, the following disease entities have been lumped into one disease, Majeed syndrome (OMIM:609682). Ten variants (missense, nonsense, and splice site) that have been reported in 7 probands in 5 publications (PMIDs: 33993107, 15994876, 37865862, 27252506, 17330256) are included in this curation. Functional data exists that confirms, p.Ser734Leu, leads to impaired protein function via loss of phosphatidic acid phosphatase activity (PMID:197717560). All probands are homozygous and none are known to be de novo. ClinVar reports at total of 37 P/LP variants which include frameshift, large deletion, and compound heterozygous variants (Bhuyan et al., PMID 33314777) but the maximum score for genetic evidence (12 pts.) has been reached. \nThe mechanism of pathogenicity appears to be loss of inhibition. This gene-disease relationship is also supported by in vitro functional assays and cell culture models (PMIDs: 28031477,33314777). Lipin-2 inhibits activation and sensitization of P2X7R, thereby regulating NLRP3 inflammasome assembly. Deficient macrophages have low intracellular cholesterol levels which alter ion currents through the P2X7R. These currents are corrected when cholesterol levels are restored in concordance with decreased inflammasome activation. Patient cells and LPIN2 deficient macrophages demonstrate increased IL-1B expression, caspase 1 activation, and osteoclastogenesis. Pit assays with patient cells demonstrate increased bone resorption. In summary, there is definitive evidence supporting the relationship between LPIN2 and autosomal recessive Majeed Syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Monogenic Autoinflammatory Disease GCEP on the meeting date May 15, 2024. (SOP Version [10])].\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/8603deb0-70e2-48f4-b485-07ddc487d8a0","GCISnapshot":"https://genegraph.clinicalgenome.org/r/6ebe7cb7-3855-465d-ab11-dcde27f1e737","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/6ebe7cb7-3855-465d-ab11-dcde27f1e737_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10139","date":"2024-05-15T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/6ebe7cb7-3855-465d-ab11-dcde27f1e737_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10139","date":"2024-05-15T14:07:00.838Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6ebe7cb7-3855-465d-ab11-dcde27f1e737_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e791ded0-4181-4aa5-9ccc-b103f4184b00_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee7d2c67-6b80-47a3-9b13-4c2a58ea58c6","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee7d2c67-6b80-47a3-9b13-4c2a58ea58c6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33993107","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a7acb82-4b4a-440f-9644-1846adf8d3dd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001375808.2(LPIN2):c.1620+5G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695227159"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/e791ded0-4181-4aa5-9ccc-b103f4184b00","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33993107","rdfs:label":" Chavan 2021 Proband 5","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/3a7acb82-4b4a-440f-9644-1846adf8d3dd"},"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0001954","obo:HP_0003565","obo:HP_0001508","obo:HP_0002754","obo:HP_0010972"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ee7d2c67-6b80-47a3-9b13-4c2a58ea58c6_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/8d6cfb98-de2b-4d60-8f7c-ae1f7a579fba_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/caddc24c-9999-4bf6-b7f8-b4dd8ecffcd0","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/caddc24c-9999-4bf6-b7f8-b4dd8ecffcd0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17330256","allele":{"id":"https://genegraph.clinicalgenome.org/r/8431a2fd-e16d-4eef-adbf-42bc51aed98d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001375808.2(LPIN2):c.2327+1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342166"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/8d6cfb98-de2b-4d60-8f7c-ae1f7a579fba","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17330256","rdfs:label":"Al-Mosawi Proband 2007","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":15,"allele":{"id":"https://genegraph.clinicalgenome.org/r/8431a2fd-e16d-4eef-adbf-42bc51aed98d"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0001954","obo:HP_0002754","obo:HP_0010972","obo:HP_0031964","obo:HP_0001433"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/caddc24c-9999-4bf6-b7f8-b4dd8ecffcd0_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/6ebe7cb7-3855-465d-ab11-dcde27f1e737_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81216ec4-a747-49bd-af29-6406e531acd4_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33993107","rdfs:label":"5 Chavan 2021 ","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/81216ec4-a747-49bd-af29-6406e531acd4","type":"Family","rdfs:label":"5 Chavan 2021 ","member":{"id":"https://genegraph.clinicalgenome.org/r/e791ded0-4181-4aa5-9ccc-b103f4184b00"}},"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/e791ded0-4181-4aa5-9ccc-b103f4184b00"}},{"id":"https://genegraph.clinicalgenome.org/r/dd19d2bc-815a-4968-a025-fe58de0199b0_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27252506","rdfs:label":"Rao 2016 Family","estimatedLodScore":1.1,"family":{"id":"https://genegraph.clinicalgenome.org/r/dd19d2bc-815a-4968-a025-fe58de0199b0","type":"Family","rdfs:label":"Rao 2016 Family","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/fa7bf197-2011-4169-bd20-699291f4ff5b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27252506","rdfs:label":"Rao Proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/670893dd-d27e-499e-9670-3e7a44a2623a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001375808.2(LPIN2):c.2241_2243delinsGG (p.Tyr747Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695227194"}},"detectionMethod":"reference a different paper to describe their methods of sequencing","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0001433","obo:HP_0001954","obo:HP_0010972","obo:HP_0001369","obo:HP_0002754","obo:HP_0003565","obo:HP_0001508"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cc60f6db-1ace-40e8-8d05-b601522ac25d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27252506","allele":{"id":"https://genegraph.clinicalgenome.org/r/670893dd-d27e-499e-9670-3e7a44a2623a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}}},"phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/fa7bf197-2011-4169-bd20-699291f4ff5b"}},{"id":"https://genegraph.clinicalgenome.org/r/faa28761-f147-459d-befb-a33f00724d7c_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15994876","rdfs:label":"Ferguson 2005 Family B","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/faa28761-f147-459d-befb-a33f00724d7c","type":"Family","rdfs:label":"Ferguson 2005 Family B","member":{"id":"https://genegraph.clinicalgenome.org/r/8f524a43-7bf0-40cb-a615-4bb73edecb31","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15994876","rdfs:label":"Ferguson Proband B","allele":{"id":"https://genegraph.clinicalgenome.org/r/1c1e8a8d-d6db-46b3-94cc-f279ed9a6677","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001375808.2(LPIN2):c.540_541del (p.Cys181Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340318"}},"firstTestingMethod":"Homozygosity mapping","phenotypes":["obo:HP_0002754","obo:HP_0010972","obo:HP_0001954"],"secondTestingMethod":"Linkage analysis","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/d0979ee5-ddbe-42b8-9d80-94cbd5ff287f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15994876","allele":{"id":"https://genegraph.clinicalgenome.org/r/1c1e8a8d-d6db-46b3-94cc-f279ed9a6677"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001954","obo:HP_0010972","obo:HP_0033605"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/8f524a43-7bf0-40cb-a615-4bb73edecb31"}},{"id":"https://genegraph.clinicalgenome.org/r/bd6f4ce1-82cd-4aa4-87c6-311746d48975_proband_segregation","type":"FamilyCosegregation","dc:description":"The genome-wide scan showed four regions o fhomozygosity and all but one were excluded by genotyping all family members for markers within the region of homozygosity. The region of interest, on the short arm of chromosome 18, was refined using 17 microsatellite markers. A maximum two point LOD score of 3.48 was obtained for marker D18S1138 at are combination fraction(h)=0 with recombination events at markers GATA178F11 and D18S1154, both marking the region of linkage (table 2). Multipoint linkage analysis produced a maximum LOD score of 4.4","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15994876","rdfs:label":"Ferguson 2005 Family A","estimatedLodScore":2.68,"family":{"id":"https://genegraph.clinicalgenome.org/r/bd6f4ce1-82cd-4aa4-87c6-311746d48975","type":"Family","rdfs:label":"Ferguson 2005 Family A","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/af9ff83c-d6fb-419f-b87e-3ba1e9cccbc6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15994876","rdfs:label":"Ferguson Proband A","allele":{"id":"https://genegraph.clinicalgenome.org/r/b72cbc1a-862e-4c8b-88d8-6c200d32ac0e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001375808.2(LPIN2):c.2201C>T (p.Ser734Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340316"}},"firstTestingMethod":"Homozygosity mapping","phenotypes":["obo:HP_0000988","obo:HP_0001954","obo:HP_0002754","obo:HP_0001433","obo:HP_0010972","obo:HP_0001508"],"secondTestingMethod":"Linkage analysis","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/00fbdf41-2c59-4d25-9501-1e465151c0ed_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15994876","allele":{"id":"https://genegraph.clinicalgenome.org/r/b72cbc1a-862e-4c8b-88d8-6c200d32ac0e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Sweet syndrome","phenotypeNegativeAlleleNegative":7,"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0002653","obo:HP_0000988","obo:HP_0001510","obo:HP_0001954"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/af9ff83c-d6fb-419f-b87e-3ba1e9cccbc6"},"publishedLodScore":4.4,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/83824e33-8ade-455c-9deb-da0d293093fd_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33993107","rdfs:label":"3 Chavan 2021","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/83824e33-8ade-455c-9deb-da0d293093fd","type":"Family","rdfs:label":"3 Chavan 2021"},"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1},{"id":"https://genegraph.clinicalgenome.org/r/bd446a80-bde4-4797-aa2d-2ec770dd9383_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33993107","rdfs:label":"2 Chavan 2021","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/bd446a80-bde4-4797-aa2d-2ec770dd9383","type":"Family","rdfs:label":"2 Chavan 2021"},"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c220128e-60af-4466-8375-be54c3354d49_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/efd71d29-614a-410c-91b4-a473ffcf348c","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/efd71d29-614a-410c-91b4-a473ffcf348c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37865862","allele":{"id":"https://genegraph.clinicalgenome.org/r/01a32444-4a07-449f-a01f-ffdcd7105d1a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001375808.2(LPIN2):c.2207G>A (p.Arg736His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8872804"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/c220128e-60af-4466-8375-be54c3354d49","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37865862","rdfs:label":"Badiger 2024 proband 1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/01a32444-4a07-449f-a01f-ffdcd7105d1a"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001954","obo:HP_0002754"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/efd71d29-614a-410c-91b4-a473ffcf348c_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/af9ff83c-d6fb-419f-b87e-3ba1e9cccbc6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00fbdf41-2c59-4d25-9501-1e465151c0ed","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00fbdf41-2c59-4d25-9501-1e465151c0ed_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID 197717560: Mouse with homologous mutation abolished PAP activity of Lipin 2. Lipin 2 via quant PCR was increased in circulating RBC and areas of lymphopoeisis. contributes to anemia","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/00fbdf41-2c59-4d25-9501-1e465151c0ed_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/af9ff83c-d6fb-419f-b87e-3ba1e9cccbc6"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/fa7bf197-2011-4169-bd20-699291f4ff5b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc60f6db-1ace-40e8-8d05-b601522ac25d","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc60f6db-1ace-40e8-8d05-b601522ac25d_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/fa7bf197-2011-4169-bd20-699291f4ff5b"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/2daa56f6-e913-4431-a57a-f50b79f16f47_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f9596d63-fdf7-4be8-8282-074d011cd0b5","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f9596d63-fdf7-4be8-8282-074d011cd0b5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37865862","allele":{"id":"https://genegraph.clinicalgenome.org/r/80e17a01-0487-48e9-bc7e-f0c2399e1e37","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001375808.2(LPIN2):c.1157C>G (p.Ser386Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA401706097"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/2daa56f6-e913-4431-a57a-f50b79f16f47","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37865862","rdfs:label":"Badiger 2024 proband 2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/80e17a01-0487-48e9-bc7e-f0c2399e1e37"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000988","obo:HP_0004840","obo:HP_0001954","obo:HP_0001369"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f9596d63-fdf7-4be8-8282-074d011cd0b5_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/8f524a43-7bf0-40cb-a615-4bb73edecb31_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d0979ee5-ddbe-42b8-9d80-94cbd5ff287f","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d0979ee5-ddbe-42b8-9d80-94cbd5ff287f_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/8f524a43-7bf0-40cb-a615-4bb73edecb31"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/6ebe7cb7-3855-465d-ab11-dcde27f1e737_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6ebe7cb7-3855-465d-ab11-dcde27f1e737_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b543ec3-78e9-49fd-9365-3eb224014b24","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3be9d125-e788-4f5e-9cda-529760a77a68","type":"Finding","dc:description":"Patients with Majeed experience sterile osteomyelitis due to altered osteoclastogenesis. Pit assay demonstrated increased bone resorption in cells from patients with Majeed syndrome. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33314777","rdfs:label":"Bhuyan 2021 Pit Assay","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/6ebe7cb7-3855-465d-ab11-dcde27f1e737_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b161e148-7b03-43b4-9c08-eccbc7880249","type":"EvidenceLine","dc:description":"Need to add large deletion as well; since patient cells were used and this is a compound heter patient","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c5299292-3955-4d6c-ade9-5d738594f125","type":"FunctionalAlteration","dc:description":"Increased Il-1B production in majeed cells compared to healthy controls. Additionally increased CXCL1, TNF, CCL2, CXCL10 in M2 (mediators of osteoclastogenesis)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33314777","rdfs:label":"Bhuyan 2021 Monocyte IL-1B expression"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5c49fa01-e918-4a46-b379-65dffb606be1","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8f1a4346-b35f-45c3-a4aa-13089a92f4ba","type":"FunctionalAlteration","dc:description":"More osteoclasts were produced in patient/Majeed cells compared to healthy control ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33314777","rdfs:label":"Bhuyan 2021 Osteoclast Differentiation"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/6ebe7cb7-3855-465d-ab11-dcde27f1e737_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/764a91a4-a07c-4d39-b0d9-efa5865a088e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cbae601e-95e7-4904-bfb1-8a680ec5bc3b","type":"Finding","dc:description":"Systemic inflammation via fevers, elevated acute phase reactants; increased inflammsome activity","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28031477","rdfs:label":"Lorden P2X7 receptor activation","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5}],"evidenceStrength":"Definitive","sequence":8293,"specifiedBy":"GeneValidityCriteria10","strengthScore":15.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/YboadK5sGlU","type":"GeneValidityProposition","disease":"obo:MONDO_0012316","gene":"hgnc:14450","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_6ebe7cb7-3855-465d-ab11-dcde27f1e737-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}